小林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4967/E01047 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/04/17 | 日証協 | 316,744株 | -2.32% | 54,218株 | +133.9% | 373,222株 | -4.21% | 12,800株 | -70.78% |
2015/04/10 | 日証協 | 324,268株 | -17.63% | 23,180株 | -74.69% | 389,634株 | -9.88% | 43,800株 | -54.29% |
2015/04/03 | 日証協 | 393,658株 | +13.96% | 91,585株 | -44.5% | 432,340株 | +10.19% | 95,820株 | +39.68% |
2015/03/20 | 日証協 | 458,947株 | -1.55% | 189,287株 | +261.78% | 513,450株 | -4.55% | 127,772株 | +127.76% |
2015/03/13 | 日証協 | 466,150株 | +0.23% | 52,321株 | -70.83% | 537,928株 | +2.66% | 56,100株 | +93.45% |
2015/03/06 | 日証協 | 465,069株 | -8.26% | 179,360株 | +0.52% | 524,004株 | -4.69% | 29,000株 | +139.43% |
2015/02/27 | 日証協 | 506,969株 | -18.48% | 178,424株 | -7.24% | 549,804株 | -12.92% | 12,112株 | -68.92% |
2015/02/20 | 日証協 | 621,919株 | -2.26% | 192,354株 | +1535.39% | 631,349株 | -1% | 38,970株 | +181.74% |
2015/02/13 | 日証協 | 636,306株 | -1.61% | 11,762株 | -93.86% | 637,706株 | -4.25% | 13,832株 | -62.62% |
2015/02/06 | 日証協 | 646,719株 | -1.58% | 191,610株 | -4.69% | 665,991株 | +0.24% | 37,002株 | +33.58% |
2015/01/30 | 日証協 | 657,123株 | -0.91% | 201,031株 | +1562.1% | 664,375株 | -1.34% | 27,700株 | +207.74% |
2015/01/23 | 日証協 | 663,155株 | -2.28% | 12,095株 | -93.4% | 673,396株 | -1.87% | 9,001株 | -74.65% |
2015/01/16 | 日証協 | 678,631株 | -1.17% | 183,235株 | -3.91% | 686,196株 | -1.79% | 35,500株 | -3.72% |
2015/01/09 | 日証協 | 686,672株 | +0.31% | 190,686株 | +803.38% | 698,696株 | +3.72% | 36,870株 | +50.28% |
2014/12/30 | 日証協 | 684,567株 | -0.92% | 21,108株 | -56.33% | 673,626株 | -1.6% | 24,534株 | -23.57% |
2014/12/26 | 日証協 | 690,908株 | +2.88% | 48,332株 | -75.5% | 684,592株 | +4.07% | 32,100株 | -21.52% |
2014/12/19 | 日証協 | 671,543株 | -2.2% | 197,241株 | -15.93% | 657,792株 | +0.18% | 40,901株 | -56.79% |
2014/12/12 | 日証協 | 686,683株 | -5.25% | 234,611株 | +186.65% | 656,619株 | -1.68% | 94,647株 | +212.05% |
2014/12/05 | 日証協 | 724,712株 | -4.39% | 81,846株 | -62.64% | 667,872株 | -1.53% | 30,331株 | +32.39% |
※株式分割は考慮していませんのでご注意ください。
Page Top